Summary 1-Naphthol was selectively toxic to human colorectal tumours compared to corresponding normal colonic tissue removed at surgery and maintained in short-term organ culture. Nineteen of 24 tumours studied have shown a significant differential response. Three human colonic adenocarcinoma xenografts, in the shortterm organ culture system, displayed the same response to l-naphthol as primary tumours removed at surgery. I-Naphthol, 1,2-and 1,4-naphthoquinone were also toxic to two human colonic adenocarcinoma cell lines, LoVo and COLO 206. The selective toxicity of l-naphthol is mediated in part through an accumulation of l-naphthol in the tumour tissue due to impaired conjugation by the tumour. The higher concentrations of 1-naphthol may then exert their toxicity either directly or by formation of naphthoquinones. Some indirect evidence was obtained for the possible involvement of 1,2-or 1,4-naphthoquinone in the cytotoxicity of 1-naphthol. Our studies suggest that further studies are warranted of the possible use of l-naphthol or related compounds as antitumour agents.
Colorectal cancer, in common with the majority of other solid tumours, has remained unresponsive, as judged by long-term survival, to current chemotherapeutic agents (Carter et al., 1981) . The reason for this failure is primarily due to the low proportion of dividing cells in carcinomas of the colon, rectum, breast and lung. In general, anticancer drugs such as the alkylating agents or antimetabolites are most effective against tumours with a high proportion of dividing cells such as the leukaemias and lymphomas (Carter et al., 1981) . The effectiveness of this type of drug is limited by host toxicity to the rapidly dividing normal tissues of the bone marrow and gut epithelium.
A major problem in colorectal cancer is that often the tumour cells have a slower growth rate than cells from the normal epithelium. Cell growth in normal colon, however, is balanced by equal cell loss by exfoliation, whereas the rate of cell loss is reduced in tumours (Weisburger et al., 1975) . Only 5-fluorouracil and the chloroethyl-nitrosoureas have shown limited utility in advanced colorectal disease achieving an objective response rate of 10-20% but without any significant effect on long-term survival (Falkson et al., 1976; Moertel, 1978) .
In this study, the effects of l-naphthol on a variety of different model colonic tumour systems were investigated. The rationale for this arose from our previous studies on routes of conjugation in normal and tumour tissue from human lung (Cohen et al., 1981) (Cohen et al., 1983a; Gibby & Cohen, 1984) . In these studies, 1-naphthol was used as a model phenolic substrate to study both glucuronidation and sulphation. We found that squamous cell carcinomas of the lung formed, almost exclusively, the glucuronic acid conjugate whilst short-term organ cultures of normal peripheral lung from the same patients formed the sulphate ester conjugate (Cohen et al., 1981) . A similar but not as dramatic difference was found between colorectal tumours and corresponding normal tissue (Cohen et al., 1983a; Gibby & Cohen, 1984) . The process of glucuronic acid conjugation requires UDPglucuronic acid as an essential co-factor. Consequently, by supplying a substrate such as 1-naphthol, the tumour tissue could be selectively depleted of UTP and thus disturb nucleic acid biosynthesis. Initially we wished to use 1-naphthol in combination with 3-deazauridine, which blocks CTP synthetase (McPartland et al., 1974) , in order to totally inhibit synthesis of cytidine nucleotides in an analogous manner to the combination of Dgalactosamine and 3-deazauridine used in the treatment of hepatomas (Lui et al., 1976) . In a preliminary study we noted that this combination did not have the desired effect, however 1-naphthol showed a marked selective toxicity to short-term organ cultures of colonic tumour tissue compared to normal colonic tissue from the same patients (Cohen et al., 1983b) . This study was therefore designed to confirm, extend and investigate the possible mechanism of the selective toxicity of 1-naphthol to short-term organ cultures of human colorectal tumour tissue compared to normal colonic tissue.
Materials and methods
Organ culture Human primary colorectal tumours and appropriate, macroscopically, normal tissue removed at surgery were transported to the laboratory, on ice, in Leibovitz L-15 medium (Gibco Biocult, Paisley, Scotland) containing 100 iu mlI penicillin, 100 pgml-1 streptomycin, 50 ug ml1 gentamycin and 50 pg ml-I fungizone.
The tissues were processed immediately, the normal mucosa was carefully excised from the muscle and connective tissue layers and macroscopically necrotic areas removed from the tumour. Both tissues were cut into 2 mm explants using a razor blade. Two strips of 3 mm gel foam (Upjohn, Kalamazoo, Missouri), previously soaked in L-15 medium; were placed on scratched surfaces at opposite ends of each compartment of a 6 x 35 mm multi-well dish (Sterilin Ltd, London, UK).
Two explants were then placed on each piece of gel foam. One ml of CMRL-1066 medium (Gibco Biocult) supplemented with 1.25% bovine albumin crystallised (Miles Biochemicals, Slough, UK), 1 mM L-glutamine, 1% D-glucose, 1 pg mlhydrocortisone, 100 iu mlP 1 penicillin, 100 jg ml1 streptomycin, 50 jg mlP gentamycin and buffered with 20mM Tricine (Gibco Biocult), was added to each well. The plates were placed in a perspex culture chamber (Bellco Glass Inc, New Jersey, USA) and gassed with 95% 02:5% CO2. The chamber was then rocked at 10 cyclesmin-m on a low profile rocker (Bellco Glass Inc.) in an incubator at 37°C.
The system was essentially the same as that described by Autrup et al. (1978) and was designed such that the tissue was submerged 50% of the time. Using this system, normal human colon can be cultured for periods of up to 20 days (Autrup et al., 1978) . In the present studies, the cultures were allowed to equilibrate for 24 h prior to their treatment for a further 24 h. The rate of incorporation of [3H]-leucine into protein remained constant throughout the 24 h treatment period in both normal and tumourous tissue.
Routine histological examination was performed on fresh and cultured specimens and tissue integrity was maintained throughout the 48 h incubation period. None of the patients had received prior chemotherapy and the series consisted of a spectrum of well to poorly differentiated carcinomas of the colon, rectum and caecum.
Cell cultures
Two human colonic adenocarcinoma cell lines, LoVo (Drewinko et al., 1976) and COLO 206 (Semple et al., 1978) When cytotoxic effects were assessed by measuring an inhibition of protein synthesis using a pulse of tritiated leucine, the radioactive precursor L-[4, 53H]-leucine (specific activity 60 Ci mmol-1, Amersham International, UK) was added to the cultures, 2 h before the end of the incubation period. In short-term organ cultures 2 pCi (100p1) was added to each compartment. At the end of the pulse period, the medium was decanted and the tissue blotted on 0.9% NaCl solution-soaked filter paper before unbound radioactivity was extracted for 10min in ice-cold 10% TCA. After extraction, the tissue was blotted again and placed in a minivial containing 100p1 of 1 M NaOH and solubilised overnight at 37°C. An aliquot of the solubilised sample was removed for protein estimation (Lowry et al., 1951) [3H] -leucine per well. The remainder of the procedure was essentially the same as for organ culture except that the cells remaining attached in each well were extracted in situ and the dpm incorporated into these cells expressed as a percentage of controls. A marked decrease in cell number was observed in cell cultures treated with higher concentrations of 1-naphthol. Thus this measure of cytotoxicity is due to both inhibition of protein synthesis in those cells remaining attached to the plate and to a decrease in cell number. COLO 206 cells were seeded into 10 x 160mm tissue culture tubes (Sterilin) at a concentration of 5 x 105 cells per tube and pulsed with 2 pCi [3H]-leucine. The remainder of the procedure was again the same as described for organ culture except that centrifugation was required between each step.
Clonogenic survival was assessed by exposing log phase monolayers of LoVo cells to various concentrations of 1-naphthol or 1,4-naphthoquinone for 24h. Attached and detached cells were harvested by trypsinisation and centrifugation of culture medium and plated onto 5 cm petri-dishes in Hams F-12. medium containing 10% FCS at appropriate cell concentrations such that -100 colonies were present after 10 days. Colonies were stained with Leishman's stain (Searle Diagnostic, Bucks.) and the cloning efficiency of the cells plated from control and treated cell cultures assessed. The average cloning efficiency of control cells over 6 experiments was 30 + 6%. After 24 h exposure to the higher concentrations of 1-naphthol (500-1,000 pM), a smaller number of cells than those originally treated were recovered following trypsinisation of the cells remaining attached to the plates and combining them with the detached cells in the medium. The results of the clonogenic assay are expressed as a percentage of control assuming that the cells lost during the treatment period would have been incapable of forming colonies in this assay.
Trypan blue exclusion was assessed in LoVo cells, after trypsinisation, and in COLO 206 cells after centrifugation, by resuspending the cells in 0.1% trypan blue in 0.9% NaCl solution. Viability was assessed by counting the percentage of the cells excluding trypan blue. The results are expressed as a percentage of control, scoring the cells lost from the cultures treated with the higher concentrations of 1-naphthol as non-viable.
Metabolism of [1-14C]-1-naphthol
The metabolism of [1-14C]-l-naphthol (Amersham International Ltd., Bucks, UK. sp. act. 19.4 Ci mmol 1) in short-term organ cultures and human colonic tumour cell lines was determined as previously described (Gibby & Cohen, 1984) .
Chemicals
All chemicals used were purchased from Sigma Chemical Co (London, England) except for 1,2-or 1,4-naphthoquinone which were obtained from Fluka, Switzerland.
Results
Assessment of cytotoxicity of J-naphthol by inhibition ofprotein synthesis, clonogenic survival and dye exclusion The cytotoxicity of 1-naphthol to LoVo cells clonogenic survival (LoVo cells only) and trypan blue exclusion. In both cell lines, a reasonable correlation was observed between these measures of cytotoxicity (Figure la and b) . A striking observation in the cell cultures treated with high concentrations of 1-naphthol (0.5-1 mM) was cell loss, presumably due to cell lysis and an inhibition of cell division, which occurred during the 24 h exposure period. For example following treatment of LoVo cells with 1 mM l-naphthol for 24 h it was only possible to recover 33% of the number of cells present in control cultures at that time. The assessment of toxicity using each of these assays varied depending on whether this cell loss was taken into account or not. For example, the ID50 values for clonogenic survival vary from 327 + 57 pM to 603 + 57 pM depending on whether the results are corrected for cell loss during exposure time or solely expressed as the cloning efficiency of the cells remaining in the culture at the end of the treatment period.
As cytotoxicity assessed by protein synthesis inhibition was in reasonable agreement with that obtained by clonogenic survival and trypan blue exclusion (Figure 1) . It was decided to use this assay as a measure of toxicity in the short-term organ cultures of the primary colorectal tumours and appropriate normal tissue, taken at surgery. This was also necessitated because of the inability to measure the toxicity to normal colon by a clonogenic assay.
The effects of J-naphthol on normal and tumour tissue from the same patients and human tumour xenografts The effects of 1 -naphthol were studied on a series of 24 human colorectal tumours and corresponding normal tissue taken at surgery and maintained in short-term organ culture ( Figure 2 ). As we had previously shown in a preliminary report (Cohen et al., 1983b) (Figure 2 ). In this model system, significant inhibition of protein synthesis in colonic tumour tissue was observed between 0.5 and 1 mM 1-naphthol whereas the normal colon was unaffected at these concentrations (Figure 2) . Human colonic tumour xenografts showed a very similar response to short-term cultures of colonic tumour tissue (Figure 2 ).
Metabolism of J-naphthol in normal and tumour tissues in relation to toxicity A possible mechanism of the selective toxicity of 1-naphthol may be the preferential depletion of uridine nucleotides in the tumour tissue, resulting from more extensive utilisation of UDP-glucuronic acid due to higher levels of glucuronic acid conjugation in the tumour tissue compared to the normal tissue (Cohen et al., 1981) . As our previous studies (Cohen et al., 1983a; Gibby & Cohen, 1984) with colonic tissue had been carried out at nontoxic concentrations of 1-naphthol (20 and 100uM) it was necessary to see if such metabolic differences also occurred at toxic concentrations of 1-naphthol (1 mM). In order to confirm and extend our previous observations, the metabolism of [1-14C]-1-naphthol was therefore studied at 20yM and 1 mM (Table I and Figure 3) . At low concentrations of 1-naphthol (20MuM), normal colon formed significantly more 1-naphthyl sulphate than 1-naphthyl-,B-D-glucuronide whereas in the tumour tissue, a marked decrease in overall metabolism and in particular in sulphate ester conjugation was observed (Table 1 and Figure 3) . The levels of the metabolites present in the normal and tumour tissue are essentially in agreement with our previous results where the metabolites in the medium were examined (Gibby & Cohen, 1984) . A different pattern of metabolism was observed at high concentrations of 1-naphthol (1 mM) when more glucuronic acid than sulphate ester conjugates were observed in both normal and tumour tissues (Table  I) . At the high concentration of 1-naphthol a marked decrease in overall metabolism in the tumour tissue was also observed (Table I and Figure 3 ). This decrease in overall metabolism suggested that more unmetabolised 1-naphthol may be present in the tumour tissue which may then exert its toxicity by some other mechanism. In order to test this hypothesis, we measured the concentrations of unmetabolised 1-naphthol present in the tissue from short-term organ cultures of normal human colon and colonic tumour tissue at various times from 4-48 h. At each time point, the toxicity was also measured by inhibition of protein synthesis. Over the time period studied, a marked increase in the selective toxicity of 1-naphthol to the tumour tissue was observed ( Figure  4a ). This was accompanied by an accumulation of unmetabolised 1-naphthol in the tumour tissue and a decrease in unmetabolised 1-naphthol in the explants of normal colon after 4h of incubation (Figure 4b ). At all times studied, the tumour tissue contained more unmetabolised 1-naphthol than the normal tissue. The changing concentrations of 1-naphthol in the tumour and normal tissue were also reflected in the metabolites of 1-naphthol found in the culture medium during the same incubations (Figure 3) . The media from the organ cultures of normal colon showed a marked increase in the concentrations of both 1-naphthyl-,B-D-glucuronide and l-naphthyl sulphate but only a very small increase in these metabolites was observed in the tumour tissue (Figure 3 ).
Metabolism of J-naphthol in human colonic tumour cell lines in relation to toxicity The metabolism and toxicity of 1-naphthol (20-1,000pM) by the human colonic tumour cell line COLO 206 were studied. More l-naphthyl-f-Dglucuronide than l-naphthyl sulphate was formed at all concentrations ( Figure 5 ). Maximal formation of the glucuronic acid conjugate was observed at a concentration of l-naphthol of 100pM which was only marginally toxic to the cells (compare Figure 5 and lb). Although the toxicity of l-naphthol to LoVo cells was similar to COLO cells (ID50 320 and 280yM respectively for inhibition of protein synthesis) the amount of glucuronic acid conjugates formed was far smaller (Table II) .
The results obtained with both the cell lines and the organ culture did not support a mechanism of selective toxicity of l-naphthol, which was dependent on uridine nucleotide depletion (see Discussion). mixed function oxidase and a reconstituted cyto-8 j chrome P-450 system to cytotoxic naphthoquinones (d'Arcy Doherty et al., 1984 Doherty et al., , 1985 . It therefore 60 c seemed possible that naphthoquinones may be Q9. involved in the toxicity of 1-naphthol to human AA 0 : colonic tumour tissue and cell lines. 1-naphthol (mM) Figure 5 Effects of the concentration of l-naphthol on its Phase II metabolism in a human colonic tumour cell line. [1-4C]-I-Naphthol (20-1,000pM) was incubated for 24h with COLO 206 cells (0.81 x 106 cells ml-1). The glucuronic acid and sulphate ester conjugates in the culture medium were separated by TLC and quantified as described in Materials and methods.
The higher concentrations of unmetabolished 1-naphthol in the tumour compared to the normal tissue suggested that more l-naphthol may be Possible involvement of naphthoquinones in J-naphthol toxicity Likely toxic metabolites from 1-naphthol are either or both 1,2-or l,4-naphthoquinone. Both are known cytotoxic agents and have been used as antifungal and putative antitumour agents in various forms (Driscoll et al., 1974) . The effect of the naphthoquinones were studied in both shortterm organ cultures of colorectal tissues (Figure 6a ) and LoVo cells (Figure 6b ). It was evident that, in both these model systems, the quinones showed greater toxicity than l-naphthol as would be expected if they were active metabolites. The toxicity of l,4-naphthoquinone to LoVo cells was very similar when assessed either by clonogenic showed a three-fold increase in activity, whilst 1,4-naphthoquinone was ten-fold more active ( Figure  6b ) (Cohen et al. 1983b) . This difference in activity may be due to the greater chemical reactivity of 1,2-naphthoquinone, which binds avidly to protein (Rees & Pirie, 1967) . When protein was removed from the medium, by omitting foetal bovine serum during the exposure period, both 1,2-and 1,4-naphthoquinone showed similar inhibition of protein synthesis (Table III) . I-Naphthol was also more toxic in the absence of serum, possibly due to a greater availability. In a preliminary study with the short-term organ culture system, the naphthoquinones were more toxic than 1-naphthol and also retained some degree of selective toxicity, to the tumour tissue compared to the normal (Figure 6a ). Some further support for the involvement of naphthoquinone formation in 1-naphthol toxicity was also suggested from experiments using dicoumarol. In LoVo cells, dicoumarol (10M) together with 1-naphthol (0.5 or 0.1 mM) produced a marked inhibition of protein synthesis, which was not observed with either agent alone. Dicoumarol was ineffective in potentiating concentrations of 1-naphthol which showed toxicity when acting alone (e.g. 0.25 and 0.5mM). In contrast to the LoVo cell line, dicoumarol showed no potentiation of l-naphthol toxicity in COLO 206 cells.
Discussion
The data presented in this study suggest a potential use of 1-naphthol or related compounds in cancer chemotherapy. Naphthols are not new to clinical studies. In 1920, Smillie reported the successful treatment of hookworm disease by administering 3 doses of 6 g of 2-naphthol over 3 days. Four of the 79 patients in the study showed severe haemolytic reactions, which in retrospect appeared to be due to glucose-6-phosphate dehydrogenase deficiency (Zinkham & Childs, 1958) . However, the use of 1-naphthol as an antitumour agent appears novel although naphthoquinones have been studied extensively in the area. A major study of the potential antitumour activity of a large number of substituted naphthoquinones was carried out by the National Institute of Health, a small number of which showed promise as chemotherapeutic agents (Driscoll et al., 1974) .
1-Naphthol was cytotoxic to colonic tumour cell lines using several criteria (Figure 1) It is the selectivity of l-naphthol against colorectal tumours compared to normal colorectal tissue that is the most important observation of this study (Figure 2 ). There are several factors which could be responsible for such selectivity. One possibility, discussed earlier, was that of a selective depletion of uridine nucleotides in the tumour tissue resulting in inhibition of nucleic acid biosynthesis. Several pieces of evidence did not support this possibility. Firstly with COLO 206 cells maximal l-naphthyl-f-D-glucuronide formation was observed with 1-naphthol (100pM), a concentration which was only marginally toxic to the cells (Figures lb and 5) . If the mechanism of toxicity had involved uridine nucleotide depletion, then one would have expected increasing glucuronic acid conjugate formation to reflect increasing nucleotide depletion and increasing toxicity. Secondly, the toxicity of l-naphthol to the human colonic tumour cell lines COLO 206 and LoVo was very similar although glucuronic acid conjugation was 23-78 fold greater in the former (Table II) . Thirdly, at concentrations of 1-naphthol (1 mM), which are selectively toxic to colonic tumour tissue compared to normal tissue, normal human colonic mucosa formed more l-naphthyl-f-D-glucuronide than tumour tissue from the same patients ( Figure  3 ). Whilst it would not appear that uridine nucleotide depletion is involved in the toxicity of 1-naphthol, it should be pointed out that differences in the pool size of uridine nucleotides either between the normal and tumour tissue or the different cell lines might also explain the data.
A second possibility for the selective toxicity of 1 -naphthol to the tumour compared to the normal tissue was the impaired Phase II conjugative metabolism in the tumour tissue (Table I and Figure 3 ). This impaired metabolism resulted in a marked progressive accumulation of l-naphthol in tumour tissue compared to normal tissue ( Figure  4b) , which corresponded to an increase in selective toxicity (Figure 4a ). It could be argued that the decreased metabolism of 1-naphthol (1 mM) in the tumour tissue was due to its greater toxicity to the tumour. However impaired conjugative metabolism (Table I and Gibby & Cohen, 1984) . The accumulation of 1-naphthol may also have been due to selective uptake into the tumour tissue. However a higher concentration of metabolites was found in the medium from the normal tissue (Figure 3 ) which must have arisen following entry of 1-naphthol into the cells. As the difference in nmoles of conjugate formed between normal and tumour tissue was much greater than the excess unmetabolised l-naphthol in the tumour tissue, it is unlikely that the observed accumulation of 1 -naphthol in the tumour tissue was due to a selective uptake.
The higher concentration of 1-naphthol in the tumour tissue may exert its toxicity directly possibly by interference with mitochondrial function (Stockdale & Selwyn, 1971) or via metabolism possibly to naphthoquinones. l-Naphthol, 1,2-and 1,4-naphthoquinone all caused a dose dependent toxicity to hepatocytes which was potentiated by dicoumarol (d'Arcy Doherty et al., 1984a) . Dicoumarol is an inhibitor of the flavoprotein enzyme NAD (P) H: (quinone acceptor) oxidoreductase otherwise known as DT-diaphorase (Ernster, 1967) . This enzyme catalyses the two electron reduction of quinones to the hydroquinone without the formation of cytotoxic semiquinone radical intermediates and thus protects against quinone toxicity produced by one electron reduction mechanisms (Thor et al., 1982) . Consequently, blocking this enzyme with dicoumarol should present greater amounts of quinone substrate to the cytotoxic pathways. Thus the potentiation of 1-naphthol toxicity observed in hepatocytes in the presence of dicoumarol is consistent with the formation of naphthoquinones. Within a narrow concentration range, dicoumarol potentiated the inhibition of protein synthesis by l-naphthol in LoVo cells and in approximately 50% of human biopsy specimens so far tested but not in COLO cells, possibly due to differences in DT-diaphorase in the different cells. Whilst this limited data suggests a possible involvement of naphthoquinones in the toxicity of 1-naphthol to tumour cells, more direct evidence is required. In addition this data does not exclude other mechanisms of toxicity.
In conclusion, this study has demonstrated the selective toxicity of l-naphthol to human colorectal tumours compared to normal colorectal tissue. The selective toxicity may be mediated through an accumulation of l-naphthol in the tumour tissue due to impaired metabolism. The l-naphthol may then mediate its toxicity either directly or by formation of cytotoxic naphthoquinones.
